Dr. Lewis is the Frank and Carla Sojonky Chair in Prostate Cancer Research at the University of Alberta, Edmonton, Alberta. In addition to his academic work, Dr. Lewis also co-founded Nanostics Inc, a diagnostics platform company as well as the CEO of ENTOS pharmaceuticals, a start-up Drug Delivery Company incorporated in 2007. His research involves cancer diagnostics, non-invasive molecular imaging and targeting of angiogenesis and metastasis using multivalent nanoparticles. He trained at The Scripps Research Institute in La Jolla, CA, developing targeted molecular imaging technologies. Dr. Lewis holds a Ph.D. in biochemistry from the University of Victoria.